May 6, 2014

Axium Healthcare Pharmacy on Tuesday announced that it has been accepted into the GlaxoSmithKline Oncology network.

May 6, 2014

In a related transaction to Tuesday morning's acquisition of Merck's OTC portfolio, Bayer also agreed to enter into a strategic pharma collaboration in the area of cardiovascular diseases with a focus on sGC modulation.

May 6, 2014

Sandoz recently announced that the generic manufacturer continues to advance its biosimilars pipeline that currently has six molecules in the Phase III clinical trial/filing prep phase.

May 6, 2014

Walgreens immunoglobulin home infusion patients reported health outcomes consistent with reported outcomes gathered by the patients’ physicians in the clinical setting, according to new Walgreens PartnerPoint Clinical Management platform data presented Friday at the American Academy of Neurology 2014 Annual Meeting in Philadelphia.

May 5, 2014

Kmart Pharmacy has announced that it is working with Diplomat Specialty Pharmacy to give Kmart customers and Shop Your Way members access to specialty medications.

May 5, 2014

Teva Pharmaceutical Industries on Monday announced that the Food and Drug Administration approved Synribo (omacetaxine mepesuccinate) for injection, to include home administration.

May 1, 2014

Diplomat will be the focus of a new campaign from GE Capital, Healthcare Financial Services.

April 30, 2014

The Food and Drug Administration on Tuesday granted approval to Zykadia (ceritinib) for patients with a specific type of late-stage (metastatic) non-small cell lung cancer (NSCLC).

April 29, 2014

Endo International on Tuesday announced that it will acquire Somar, a privately-owned specialty pharmaceuticals company based in Mexico City, Mexico.

April 28, 2014

As lifetime earnings for pharmaceuticals decrease, commercialization expenses increase and payers tighten their belts on reimbursement, life science companies will be faced with shrinking margins over the next few years.

April 27, 2014

Nuanced and intuitive leadership. That’s how Steve Anderson, president and CEO for the National Association of Chain Drug Stores, characterized today’s state of the NACDS — a body made greater by the sum of its parts that has successfully navigated the complexities of today’s evolving healthcare environment, as well as the intricacies of the political arena — on Sunday during his address before attendees of the NACDS Annual Meeting 2014.

April 25, 2014

McKesson Specialty Health has announced the integration of its distribution services with General Medical Services’ Physician Office Drug Inventory System, an alliance that creates the first end-to-end integrated inventory and order-to-reimbursement verification solution designed specifically for ophthalmologists.

April 24, 2014

AmerisourceBergen posted double-digit gains in second quarter revenue, reflecting a gain in both the AmerisourceBergen Drug Corp. and the AmerisourceBergen Specialty Group.

April 24, 2014

Armada Health Care, a provider for channel management solutions, commercialization strategies, and support services for the specialty pharmaceutical industry, has announced the launch of a new specialty pharmacy software solution called Vision Armada Analytics.

April 24, 2014

CVS/pharmacy is teaming up with The Partnership at Drugfree.org to create a community donation program through which local police departments can apply to receive a drug collection unit to help their communities safely dispose of unwanted medications, including controlled substances, the pharmacy retailer announced on Thursday.

April 24, 2014

Endo International announced that its affiliates have acquired rights to Sumavel DosePro (sumatriptan injection) for subcutaneous use from Zogenix.

April 24, 2014

The Food and Drug Administration on Wednesday approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease, a rare disorder similar to lymphoma (cancer of the lymph nodes).

April 23, 2014

Bayer HealthCare on Tuesday announced that the Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation for Bayer's investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) for the treatment of non-cystic fibrosis bronchiectasis.

April 23, 2014

Specialty pharmacy operator Diplomat has access to dispense Arzerra, a cancer treatment with a recently expanded indication, the company noted Tuesday.

April 22, 2014

Eli Lilly on Monday announced that the Food and Drug Administration has approved Cyramza (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

April 22, 2014

Novartis on Tuesday made a number of moves that have fundamentally reshaped its business, according to published reports.

April 21, 2014

Boehringer Ingelheim Pharmaceuticals has announced that the Food and Drug Administration and European Commission have granted Orphan Drug Designation to volasertib for acute myeloid leukemia.

April 21, 2014

GlaxoSmithKline and Genmab A/S announced last week that the Food and Drug Administration has approved a supplemental biologic license application for the use of Arzerra (ofatumumab) in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia for whom fludarabine-based therapy is considered inappropriate.

April 14, 2014

AssistRx last week introduced a new technology that simplifies the prescribing of specialty therapies while streamlining communications between prescribers, pharmacies, patients and manufacturers. It’s smart technology that can lead to patients receiving specialty medications weeks earlier than ever before, the company claimed.